mr 2034 has been researched along with phencyclidine in 2 studies
Studies (mr 2034) | Trials (mr 2034) | Recent Studies (post-2010) (mr 2034) | Studies (phencyclidine) | Trials (phencyclidine) | Recent Studies (post-2010) (phencyclidine) |
---|---|---|---|---|---|
48 | 0 | 0 | 28,294 | 387 | 7,796 |
Protein | Taxonomy | mr 2034 (IC50) | phencyclidine (IC50) |
---|---|---|---|
Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 0.1299 | |
Lysosomal Pro-X carboxypeptidase | Homo sapiens (human) | 0.091 | |
Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 0.1299 | |
Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 0.1299 | |
Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 0.1299 | |
Glutamate receptor ionotropic, NMDA 1 | Homo sapiens (human) | 0.5563 | |
Glutamate receptor ionotropic, NMDA 2A | Homo sapiens (human) | 0.205 | |
Glutamate receptor ionotropic, NMDA 2B | Homo sapiens (human) | 1.2589 | |
Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 0.1299 | |
Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 0.1299 | |
Sigma non-opioid intracellular receptor 1 | Rattus norvegicus (Norway rat) | 0.53 | |
Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 0.1299 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brantl, V; Emrich, HM; Herz, A; Pfeiffer, A | 1 |
Altura, BM; Altura, BT; Quirion, R | 1 |
2 other study(ies) available for mr 2034 and phencyclidine
Article | Year |
---|---|
Psychotomimesis mediated by kappa opiate receptors.
Topics: Adult; Anxiety; Benzomorphans; Humans; Male; Middle Aged; Morphinans; Naloxone; Personality Tests; Phencyclidine; Receptors, Opioid; Receptors, Opioid, kappa | 1986 |
Identification of benzomorphan-kappa opiate receptors in cerebral arteries which subserve relaxation.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Benzomorphans; Cerebral Arteries; Cyclazocine; Dinoprost; Dogs; Drug Interactions; Ethylketocyclazocine; Female; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Phencyclidine; Prostaglandins F; Pyrrolidines; Receptors, Opioid; Receptors, Opioid, kappa | 1984 |